1 / 39

PROTEIN SYNTHESIS INHIBITORS

PROTEIN SYNTHESIS INHIBITORS. INTRODUCTION. These antibiotics exert their actions by targeting the bacterial ribosomal subunit at various steps in the synthesis of bacterial protein. Bacterial ribosome is smaller 70 s as compared to the mammalian cytoplasmic ribosome - 80 s.

darby
Download Presentation

PROTEIN SYNTHESIS INHIBITORS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PROTEIN SYNTHESIS INHIBITORS

  2. INTRODUCTION • These antibiotics exert their actions by targeting the bacterial ribosomal subunit at various steps in the synthesis of bacterial protein. • Bacterial ribosome is smaller 70 s as compared to the mammalian cytoplasmic ribosome - 80 s

  3. CLASSES OF DRUGS • AMINOGLYCOSIDES • TETRACYCLINES • GLYCYLCYCLINE • CHLORAMPHENICOL • MACROLIDES • CLINDAMYCIN • LINEZOLID • DALFOQUISTIN/ QUINOPRISTIN

  4. p. 554 Azithromycin (Zithromax) Very broad spectrum. Aerobic gm +/- SE: Toxicity Nephro- Oto-toxic Very broad spectrum. Many gm +, some gm – Pen allergic pt SE: GI distress Gm+/- bacteria Spirochetes, Rickettsiae Resistant organisms SE: GI distress Photosensitivity Impair teeth & bone growth Chloramphenicol: many Gm -/+ bacteria Serious infxn. SE: Bone marrow aplasia Clindamycin: Most Gm +, some Gm – Alternative use. SE: colitis - PMC (C. difficile) Ethionamide: TB SE: GI distress

  5. Aminoglycosides • THEY ARE BACTERICIDAL. • Susceptible organisms allow aminoglycosides to diffuse through their porin channels in their outer membranes. • These organisms have oxygen dependant system that transports the drug across cell membrane.

  6. Aminoglycosides • Streptomycin • Gentamicin • Tobramycin • Amikacin • Neomycin

  7. MOA: They bind to the 30s ribosomal subunit distorting its structure, thus interfering with the assembly of functional ribosomal apparatus(initiation). • They also allow for misreading resulting in mutation or premature chain termination • Synergism: They synergize with beta lactAM ANTIBIOTICS BECAUSE OF THE LATTERS ACTION ON CELL WALL SYNTHESIS, WHICH ENHANCES DIFFUSION OF THE AMINOGLYCOSIDES INTO THE BACTERIUM.

  8. Actions • THAY ARE EFFECTIVE AGAINST AEROBIC GRAM -VE BACILLI and RODS AS ANEROBES LACK THE OXYGEN REQUIRING TRANSPORT SYSTEM. • Synergistic action occur for infections caused by enterococci and pseudomonas

  9. Organisms susceptible to aminoglycosides • Klebsiella • Francisella tularensis • Yersinia pestis • Brucella • STREPTOMYCIN IS USED TO TREAT TB, PLAGUE & TULAREMIA.

  10. Resistance • Decreased uptake of drug due to absence of Porin channels and oxygen dependent uptake system • Altered 30 s subunit • Plasmid associated synthesis of conjugating enzymes such as acetyl transferase that eliminates the drug faster.

  11. Aminoglycosides Route : parenteral • Exception : neomycin –topical and sometimes oral for hepatic coma. • The bacteriocidal effect is conc and time dependent i.e., the greater the conc of drug, the greater the bacteria killing. • Toxicity is dependent on drug concentration and thus once daily dosing is recommended which results in fewer toxicities. • Distribution : low conc. in CSF, • Crosses placenta

  12. Excretion : Glomerular filtration • HIGH CONCENTRATIONS ACCUMULATE IN THE RENAL CORTEX, ENDOLYMPH AND PERILYMPH OF INNER EAR

  13. Aminoglycosides - SE • OTO TOXICITY • DEAFNESS (irreversible), VERTIGO (reversible) may be enhanced by loop diuretics • NEPHRO – TOXICITY: includes acute tubular necrosis which is usually reversible but enhanced by vancomycin, ampho-B, cisplatin • NEURO MUSCULAR PARALYSIS- ↓ release of Ach • RX – mostly calcium gluconate or neostigmine can reverse the situation • CONTACT DERMATITIS –neomycin

  14. Tetracyclines • Doxycycline • Minocycline • demeclocycline

  15. TETRACYCLINES • Consist of 4 fused rings with a system of conjugated double bonds. • Broad spectrum antibiotics • Are bacteriostatic • MOA: THEY BIND TO THE 30S SUBUNIT OF THE BACTERIAL RIBOSOME AND BLOCK ACCESS OF THE AMINO ACYL-TRNA TO THE MRNA-RIBOSOME COMPLEX AT THE ACCEPTOR SITE. THUS THEY INHIBIT BACTERIAL PROTEIN SYNTHESIS.

  16. Actions • Effective against gram +ve & -ve organisms. • Good activity against: chlamydial and mycoplasmal species, H-pylori, Rickettsia, Borrelia burgdoferi, Brucella and Vibrio • Backup to penicillin G in syphilis • Demeclocycline can be used to treat SIADH

  17. TETRA CYCLINES • ROUTE : ORAL ,DECREASED BY • MILK • ANTACIDS • IRON SUPPLEMENTS • DISTRIBUTION :CROSSES BBB but not sufficient for therapeutic efficacy except Minocycline. • All tetracyclines readily crosses placenta. • High levels in calcium tissues- bones, teeth, some tumors • Excretion :renal , exception – doxycycline ( In bile )

  18. Resistance • Production of an efflux pump by bacteria which causes elimination of the drug resulting in decreased conc of drug intracellularly.

  19. TETRA CYCLINES - SE • MC : GIT- epigastric discomfort, • CALCIUM DEPOSITION : GROWTH –STUNTED, TEETH – SMALL,DISCOLORED • PHOTO TOXICITY • HEPATO TOXICITY in pregnant women(high doses) • VERTIGO – MINOCYCLINE • SUPERINFECTION: overgrowth of candida and C.dificile causing pseudomemranous colitis • CI : WOMEN – preg, lactating, children(<8yrs)

  20. GLYCYLCYCLINES • TIGECYCLINE: structurally similar to the tetracyclines • Has a broad-spectrum of activity against: • Gram –ve organisms • Anaerobic organisms • Its bacteriostatic • MOA: Binds to 30s ribosomal subunit preventing the binding of aminoacyl t-RNA to the A-site. • SE: SIMILAR TO TETRACYCLINE

  21. Macrolides • Erythromycin • Telithromycin • Azithromycin • Clarithromycin

  22. Macrolides • Are bacteriostatic • Macrolides bind to 50 s subunit of the bacterial ribosome thus inhibiting the translocation steps of protein synthesis.

  23. Erythromycin • Indication –effective against : • gram +ve cocci (not MRSA) • Legionella pneumophilia, • Campylobacter jejuni • Atypical organism: chlamydia, mycoplasma and ureaplasma species • used in pt. with allergy to penicillins

  24. ACTIONS Clarithromycin • Spectrum : - Haemophilus INFLUENZA, urethritis caused by chlamydia trachromatis Azithromycin • Spectrum: Moraxella & H-influenza related respiratory pneumonias and M. Avium in AIDs pts

  25. Macrolides • Route : • Erythromycin is given orally but are destroyed by acid and so the enteric coated or esterified form is usually given. • Clari and azithromycin: orally and stable to acid • IV – for azithromycin also • Distribution : CSF – poor. • Prostate – good • Excretion : in bile by erythromycin and clarithromycin • Exception – Azithromycin – renal

  26. Erythromycin and clarithromycin: are not safe in pregnancy and inhibit cyt P450 • Azithromycin: safe in pregnancy and does not inhibit cyt P450

  27. Resistance • Ability of the bacteria to methylate a base in the 23s subunit of rRNA. • Presence of a plamid associated erythromycin esterase which inactivates the drug. • Presence of an efflux pump which limits the conc of drug intracellularly

  28. Macrolides - SE • MC : GIT DISTRESS • OTO TOXICITY: which is reversible • CHOLESTATIC JAUNDICE • CI : LIVER FAILURE

  29. chloramphenicol • MOA: BINDS TO THE 50 S RIBOSOMAL SUBUNIT THEREBY INHIBITING THE PEPTIDYL TRANSFERASE REACTION.

  30. Actions • Broad spectrum antibiotic • Active against rickettsiae • Salmonella typhi • Bacteriodes Fragilis • Can be bactericidal (more commonly) or bacteriostatic depending on the organism.

  31. Resistance • RESISTANCE IS BECAUSE OF R FACTOR WHICH CODES FOR ACETYL CO-A transferase that inactivates the drug

  32. CHLORAMPHENICOL • ROUTE : ORAL / IV • DISTRIBUTION : CROSSES BBB • Metabolized by hepatic conjugation to metabolite called glucuronide • EXCRETION : of glucuronide renally • SE: GRAY- BABY SYNDROME- due to poor conjugating capacity and under developed renal function. Accumulation leads to interference with function of mitochondrial ribosomes. • HEMOLYTIC ANEMIA : G 6 PD DEFICIENCY

  33. Clindamycin • MOA and Resistance: same as macrolides • INDICATION: infections caused by anerobes such as BACTERIODES FRAGILIS, osteomyelitis due to gram +ve cocci • ROUTE : ORAL • EXCRETION : RENAL & HEPATIC • SE : MC is PSEUDOMEMBRANOUS COLITIS • Treatment of pseudomembranous colitis: first choice- metronidazole and then vancomycin

  34. QUINOPRISTIN/DALFOPRISTIN • Quinipristin/dalfopristin • Mixture of two streptogramins in a ratio of 30 to 70. • MOA: Each component of this combination binds to a separate site on 50 s bacterial ribosome interfering with the binding of amino acyl tRNA with acceptor site. • Active against VRSA & VRE

  35. LINEZOLID • Effective against gram +ve organism such VRSA & VRE • MOA: binds to the 50s subunit Inhibits formation of 70 s initiation complex and thus inhibits protein synthesis. • It is bacteriostatic • Inhibits MAO, so caution must be exercised by pts taking tyramine containing foods

More Related